Lv3
228 积分 2025-12-21 加入
Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats
15天前
已完结
Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation
15天前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
16天前
已完结
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
16天前
已完结
MASH and the race for liver antifibrotics
16天前
已完结
Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis
16天前
已完结
Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis
16天前
已完结
A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo
16天前
已完结
Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD)
16天前
已完结
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier
17天前
已完结
皖公网安备34019202002308
